« Back
Home /
hVEGF-IN-1

hVEGF-IN-1

Item no.	TMO-T4288-100mg
Manufacturer	TargetMol
CASRN	1637443-98-1
Amount	100 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 1 mg 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category	Oncology By Cell Type Carcinoma Cell Biology Cell Culture Cytokines Adenocarcinoma Reagents & Chemicals Molecules By Organ Bladder Cancer Colorectal Cancer
Type	Molecules
Specific against	other
Citations	1. Discovery of Small Molecules for Repressing Cap-Independent Translation of Human VascularEndothelial Growth Factor (hVEGF) as Novel Antitumor Agents. J Med Chem. 2017 Jul 13;60(13):5306-5319.
Smiles	CCN(CC)CCOc1ccc(Nc2nc(nc3ccccc23)-c2ccccc2NC(=O)CCN2CCN(C)CC2)cc1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Shipping Condition	Cool pack
Available
Manufacturer - Targets	VEGFR
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	581.75
Description	hVEGF-IN-1 inhibits human VEGF-A translation and has antitumor activity.
Pathways	Tyrosine Kinase/Adaptors\|\|\|Angiogenesis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T4288-100mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question